ATC Group: A07EC01 Sulfasalazine

Anatomical Therapeutic Chemical Classification System

Hierarchical position in ATC classification

Level
Code
Title
1
Alimentary tract and metabolism
2
Antidiarrheals, intestinal antiinflammatory/antiinfective agents
3
Intestinal antiinflammatory agents
4
Aminosalicylic acid and similar agents
5
A07EC01
Sulfasalazine

Defined daily dose

The DDD is the assumed average maintenance dose per day for a drug used for its main indication in adults. The DDD is a unit of measurement and does not necessarily reflect the recommended or Prescribed Daily Dose. Therapeutic doses for individual patients and patient groups will often differ from the DDD as they will be based on individual characteristics (such as age, weight, ethnic differences, type and severity of disease) and pharmacokinetic considerations.

Route
Amount
ORAL - Oral
2 g
RECTAL - Rectal
2 g

Active ingredients

Active Ingredient
Description

Therapeutic benefit of sulfasalazine appears to be due to a local action of the sulfasalazine and its split product 5-aminosalicylic acid on the mucous membrane and deeper colonic structures.

Medicines in this ATC group

Drug
Countries

Germany United States

South Africa

Australia

Cyprus Lithuania

Australia Austria Canada Estonia Finland ...

Germany Spain

France Netherlands Tunisia

Hong Kong

Hong Kong

Related product monographs

Title
Type
Country
Structured Product Labeling (SPL)
US
Summary of Product Characteristics (SPC)
UK